KYMR
Price
$89.68
Change
+$1.87 (+2.13%)
Updated
Dec 12 closing price
Capitalization
7.17B
68 days until earnings call
Intraday BUY SELL Signals
ZNTL
Price
$1.40
Change
-$0.05 (-3.45%)
Updated
Dec 12 closing price
Capitalization
101.15M
81 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs ZNTL

Header iconKYMR vs ZNTL Comparison
Open Charts KYMR vs ZNTLBanner chart's image
Kymera Therapeutics
Price$89.68
Change+$1.87 (+2.13%)
Volume$1.86M
Capitalization7.17B
Zentalis Pharmaceuticals
Price$1.40
Change-$0.05 (-3.45%)
Volume$366K
Capitalization101.15M
KYMR vs ZNTL Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. ZNTL commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a StrongBuy and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (KYMR: $87.81 vs. ZNTL: $1.45)
Brand notoriety: KYMR and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 147% vs. ZNTL: 37%
Market capitalization -- KYMR: $7.17B vs. ZNTL: $101.15M
KYMR [@Biotechnology] is valued at $7.17B. ZNTL’s [@Biotechnology] market capitalization is $101.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both KYMR and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 3 TA indicator(s) are bullish while ZNTL’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 3 bullish, 3 bearish.
  • ZNTL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than ZNTL.

Price Growth

KYMR (@Biotechnology) experienced а +32.58% price change this week, while ZNTL (@Biotechnology) price change was +3.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($7.17B) has a higher market cap than ZNTL($101M). KYMR YTD gains are higher at: 118.270 vs. ZNTL (-52.145). ZNTL has higher annual earnings (EBITDA): -152.83M vs. KYMR (-286.52M). KYMR has more cash in the bank: 506M vs. ZNTL (281M). ZNTL has less debt than KYMR: ZNTL (36.7M) vs KYMR (84M). KYMR has higher revenues than ZNTL: KYMR (43.7M) vs ZNTL (26.9M).
KYMRZNTLKYMR / ZNTL
Capitalization7.17B101M7,103%
EBITDA-286.52M-152.83M187%
Gain YTD118.270-52.145-227%
P/E RatioN/AN/A-
Revenue43.7M26.9M162%
Total Cash506M281M180%
Total Debt84M36.7M229%
TECHNICAL ANALYSIS
Technical Analysis
KYMRZNTL
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 24 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PUMSY2.420.11
+4.76%
Puma SE
MTNOF9.47N/A
N/A
MTN Group Ltd.
RDRIF0.32N/A
N/A
New Stratus Energy Inc.
QPRC0.32N/A
N/A
Quest Patent Research Corporation
SWZNF4626.31N/A
N/A
Schweizerische Nationalbank

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-2.31%
NRIX - KYMR
62%
Loosely correlated
-2.75%
WVE - KYMR
55%
Loosely correlated
-17.20%
OCUL - KYMR
54%
Loosely correlated
-4.80%
VERA - KYMR
52%
Loosely correlated
+3.79%
GPCR - KYMR
51%
Loosely correlated
-2.18%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with NGNE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+2.11%
NGNE - ZNTL
49%
Loosely correlated
+2.41%
SYRE - ZNTL
48%
Loosely correlated
-0.87%
MGNX - ZNTL
47%
Loosely correlated
+0.71%
RXRX - ZNTL
45%
Loosely correlated
-3.98%
FATE - ZNTL
45%
Loosely correlated
+1.83%
More